Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 FDA Approval of Remdesivir

Literature DB >> 33264539

FDA Approval of Remdesivir - A Step in the Right Direction.

Daniel Rubin¹, Kirk Chan-Tack¹, John Farley¹, Adam Sherwat¹.

Abstract

Entities: Chemical

Year: 2020 PMID： 33264539 DOI： 10.1056/NEJMp2032369

Source DB: PubMed Journal: N Engl J Med ISSN： 0028-4793 Impact factor: 91.245

Keyword Cloud
Cited

× No keyword cloud information.

55 in total

Review 1. Inhibition of the main protease of SARS-CoV-2 (M^pro) by repurposing/designing drug-like substances and utilizing nature's toolbox of bioactive compounds.

Authors: Io Antonopoulou; Eleftheria Sapountzaki; Ulrika Rova; Paul Christakopoulos
Journal: Comput Struct Biotechnol J Date: 2022-03-14 Impact factor: 7.271

Review 2. Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants.

Authors: Cong Sun; Chu Xie; Guo-Long Bu; Lan-Yi Zhong; Mu-Sheng Zeng
Journal: Signal Transduct Target Ther Date: 2022-06-28

3. Synthesis and greener pastures biological study of bis-thiadiazoles as potential Covid-19 drug candidates.

Authors: Musa A Said; Sayed M Riyadh; Nadia S Al-Kaff; A A Nayl; Khaled D Khalil; Stefan Bräse; Sobhi M Gomha
Journal: Arab J Chem Date: 2022-07-11 Impact factor: 6.212

4. Synthesis and anti-SARS-CoV-2 activity of deuterated GS-441524 analogs.

Authors: Wei Zheng; Tianwen Hu; Yumin Zhang; Daibao Wei; Yuanchao Xie; Jingshan Shen
Journal: Tetrahedron Lett Date: 2022-07-09 Impact factor: 2.032

5. Hybrid physiologically-based pharmacokinetic model for remdesivir: Application to SARS-CoV-2.

Authors: James M Gallo
Journal: Clin Transl Sci Date: 2021-05-01 Impact factor: 4.689

Review 6. COVID-19 Pandemic: Advances in Diagnosis, Treatment, Organoid Applications and Impacts on Cancer Patient Management.

Authors: Chenyang Ye; Lina Qi; Ji Wang; Shu Zheng
Journal: Front Med (Lausanne) Date: 2021-03-29

7. Virtual screening of peptides with high affinity for SARS-CoV-2 main protease.

Authors: William Farias Porto
Journal: Comput Biol Med Date: 2021-04-02 Impact factor: 6.698

8. Association of Remdesivir Treatment With Survival and Length of Hospital Stay Among US Veterans Hospitalized With COVID-19.

Authors: Michael E Ohl; Donald R Miller; Brian C Lund; Takaaki Kobayashi; Kelly Richardson Miell; Brice F Beck; Bruce Alexander; Kristina Crothers; Mary S Vaughan Sarrazin
Journal: JAMA Netw Open Date: 2021-07-01

9. Can remdesivir and its parent nucleoside GS-441524 be potential oral drugs? An in vitro and in vivo DMPK assessment.

Authors: Jiashu Xie; Zhengqiang Wang
Journal: Acta Pharm Sin B Date: 2021-03-22 Impact factor: 11.413

10. Is PF-00835231 a Pan-SARS-CoV-2 Mpro Inhibitor? A Comparative Study.

Authors: Mohammad Hassan Baig; Tanuj Sharma; Irfan Ahmad; Mohammed Abohashrh; Mohammad Mahtab Alam; Jae-June Dong
Journal: Molecules Date: 2021-03-17 Impact factor: 4.411

Review 1. Inhibition of the main protease of SARS-CoV-2 (Mpro) by repurposing/designing drug-like substances and utilizing nature's toolbox of bioactive compounds.

Review 2. Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants.

Review 6. COVID-19 Pandemic: Advances in Diagnosis, Treatment, Organoid Applications and Impacts on Cancer Patient Management.

Review 1. Inhibition of the main protease of SARS-CoV-2 (M^pro) by repurposing/designing drug-like substances and utilizing nature's toolbox of bioactive compounds.